BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 15106188)

  • 1. Radiofrequency thermal ablation versus other interventions for hepatocellular carcinoma.
    Galandi D; Antes G
    Cochrane Database Syst Rev; 2004; (2):CD003046. PubMed ID: 15106188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiofrequency thermal ablation versus other interventions for hepatocellular carcinoma.
    Galandi D; Antes G
    Cochrane Database Syst Rev; 2002; (3):CD003046. PubMed ID: 12137670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma.
    Weis S; Franke A; Mössner J; Jakobsen JC; Schoppmeyer K
    Cochrane Database Syst Rev; 2013 Dec; (12):CD003046. PubMed ID: 24357457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma.
    Weis S; Franke A; Berg T; Mössner J; Fleig WE; Schoppmeyer K
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD006745. PubMed ID: 25620061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis.
    Majumdar A; Roccarina D; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011650. PubMed ID: 28351116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma.
    Schoppmeyer K; Weis S; Mössner J; Fleig WE
    Cochrane Database Syst Rev; 2009 Jul; (3):CD006745. PubMed ID: 19588401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ablative and non-surgical therapies for early and very early hepatocellular carcinoma: a systematic review and network meta-analysis.
    Wade R; South E; Anwer S; Sharif-Hurst S; Harden M; Fulbright H; Hodgson R; Dias S; Simmonds M; Rowe I; Thornton P; Eastwood A
    Health Technol Assess; 2023 Dec; 27(29):1-172. PubMed ID: 38149643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combination of transcatheter arterial chemoembolisation (TACE) and thermal ablation versus TACE alone for hepatocellular carcinoma.
    Liu B; Zhang Y; Chen H; Li W; Tsochatzis E
    Cochrane Database Syst Rev; 2022 Jan; 1(1):CD013345. PubMed ID: 34981511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryotherapy for hepatocellular carcinoma.
    Awad T; Thorlund K; Gluud C
    Cochrane Database Syst Rev; 2009 Oct; (4):CD007611. PubMed ID: 19821432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma.
    Abdel-Rahman OM; Elsayed Z
    Cochrane Database Syst Rev; 2016 Feb; 2():CD011313. PubMed ID: 26905230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous ethanol injection for liver metastases.
    Riemsma RP; Bala MM; Wolff R; Kleijnen J
    Cochrane Database Syst Rev; 2013 May; (5):CD008717. PubMed ID: 23728679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiofrequency thermal ablation vs. percutaneous ethanol injection for small hepatocellular carcinoma in cirrhosis: meta-analysis of randomized controlled trials.
    Orlando A; Leandro G; Olivo M; Andriulli A; Cottone M
    Am J Gastroenterol; 2009 Feb; 104(2):514-24. PubMed ID: 19174803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma: a meta-analysis of randomized controlled trials.
    Qi X; Tang Y; An D; Bai M; Shi X; Wang J; Han G; Fan D
    J Clin Gastroenterol; 2014; 48(5):450-7. PubMed ID: 24172183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current role of local ablative treatments for hepatocellular carcinoma.
    Huang GT; Liang JD; Sheu JC
    J Formos Med Assoc; 2004 Jun; 103(6):403-10. PubMed ID: 15278182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma in patients with chronic liver disease: a randomised controlled phase 2 trial.
    Vietti Violi N; Duran R; Guiu B; Cercueil JP; Aubé C; Digklia A; Pache I; Deltenre P; Knebel JF; Denys A
    Lancet Gastroenterol Hepatol; 2018 May; 3(5):317-325. PubMed ID: 29503247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma.
    Shiina S; Teratani T; Obi S; Sato S; Tateishi R; Fujishima T; Ishikawa T; Koike Y; Yoshida H; Kawabe T; Omata M
    Gastroenterology; 2005 Jul; 129(1):122-30. PubMed ID: 16012942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamoxifen for hepatocellular carcinoma.
    Nowak A; Findlay M; Culjak G; Stockler M
    Cochrane Database Syst Rev; 2004; (3):CD001024. PubMed ID: 15266436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous radiofrequency ablation of hepatocellular carcinoma compared to percutaneous ethanol injection in treatment of cirrhotic patients: an Italian randomized controlled trial.
    Giorgio A; Di Sarno A; De Stefano G; Scognamiglio U; Farella N; Mariniello A; Esposito V; Coppola C; Giorgio V
    Anticancer Res; 2011 Jun; 31(6):2291-5. PubMed ID: 21737654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous ablation for small hepatocellular carcinoma.
    Yin XY; Lu MD
    Expert Rev Gastroenterol Hepatol; 2009 Apr; 3(2):121-30. PubMed ID: 19351283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiofrequency ablation in the treatment of liver metastases from colorectal cancer.
    Cirocchi R; Trastulli S; Boselli C; Montedori A; Cavaliere D; Parisi A; Noya G; Abraha I
    Cochrane Database Syst Rev; 2012 Jun; (6):CD006317. PubMed ID: 22696357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.